These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2482112)

  • 1. Prostate specific antigen--a screening test for prostatic cancer?
    Powell CS; Fielding AM; Rosser K; Ames AC; Vaughton KC
    Br J Urol; 1989 Nov; 64(5):504-6. PubMed ID: 2482112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
    van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen (PSA) in the management of 500 prostatic patients.
    Guillet J; Role C; Duc AT; François H
    Am J Clin Oncol; 1988; 11 Suppl 2():S61-2. PubMed ID: 2468274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
    Dupont A; Cusan L; Gomez JL; Thibeault MM; Tremblay M; Labrie F
    J Urol; 1991 Oct; 146(4):1064-7; discussion 1067-8. PubMed ID: 1716697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is prostate-specific antigen the most useful marker for screening in prostate cancer?
    Delaere KP; Van Dieijen-Visser MP; Gijzen AH; Brombacher PJ
    Am J Clin Oncol; 1988; 11 Suppl 2():S65-7. PubMed ID: 2468276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
    Fincker F; Sauvan R; Pasquier J
    Am J Clin Oncol; 1988; 11 Suppl 2():S68-70. PubMed ID: 2468277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
    Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
    Oosterom R; Bogdanowicz J; Schröder FH
    Eur Urol; 1989; 16(4):253-7. PubMed ID: 2475344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of PSA and PAP in patients with or without prostatic cancer.
    Caty A; Gosselin P; Cazin JL; Dehaut JM; Adenis L
    Am J Clin Oncol; 1988; 11 Suppl 2():S63-4. PubMed ID: 2468275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
    Buamah PK; Johnson P; Skillen AW
    Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.
    Morote J; Ruibal A; Palou J; de Torres JA; Soler-Roselló A
    Int J Biol Markers; 1988; 3(1):23-8. PubMed ID: 2470838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
    Hetherington JW; Siddall JK; Cooper EH
    Eur Urol; 1988; 14(1):1-5. PubMed ID: 2449352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
    Csapo Z; Brand K; Walther R; Fokas K
    J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
    Daver A; Soret JY; Coblentz Y; Allain YM; Cellier P; Chauveau P
    Am J Clin Oncol; 1988; 11 Suppl 2():S53-60. PubMed ID: 2468273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
    Huang CL; Brassil D; Rozzell M; Schellhammer PF; Wright GL
    Prostate; 1993; 23(3):201-12. PubMed ID: 7694265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
    Turkes A; Nott J; Turkes AO; Griffiths K
    Am J Clin Oncol; 1988; 11 Suppl 2():S77-9. PubMed ID: 2468280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F; Zambolin T; Bonora R; Panteghini M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
    van Dieijen-Visser MP; Hendriks MW; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 Sep; 177(1):77-80. PubMed ID: 2460272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.